Androgen replacement therapy in women

Fertility and Sterility

Volumn 82, Issue 2, 2004, Pages 273-289

  Cameron, Deborah R ^a   Braunstein, Glenn D ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

androgen insufficiency syndrome; Androgen replacement therapy; female sexual dysfunction; hypoactive sexual desire disorder; libido; oophorectomy; testosterone replacement

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ANTICONVULSIVE AGENT; BENZOIC ACID; CONJUGATED ESTROGEN; DIETHYLSTILBESTROL; ESTRATEST; ESTROGEN; GLUCOCORTICOID; MEDROXYPROGESTERONE ACETATE; METHYLTESTOSTERONE; PRASTERONE; PROPIONIC ACID DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE; TIBOLONE;

ACNE; ADRENALECTOMY; BIOAVAILABILITY; BODY COMPOSITION; CLINICAL TRIAL; DRUG FORMULATION; DRUG SAFETY; ENERGY; FATIGUE; FOOD AND DRUG ADMINISTRATION; HEALTH; HIRSUTISM; HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; LIBIDO; MEDLINE; MUSCLE MASS; OVARIECTOMY; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUALITY; SIDE EFFECT; WELLBEING;

EID: 4143056870     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2003.11.062     Document Type: Article

References (104)

1. American Psychiatric Association. DSM-IV. Diagnostic and Statistical Manual of Mental Disorders. 4th ed:1994;American Psychiatric Press, Washington, D.C.
2. Basson R., Berman J., Burnett A., Derogatis L., Ferguson D., Fourcroy J., et al. Report of the international consensus development conference of female sexual dysfunction definitions and classifications. J Urol. 163:2000;888-893
3. Bachmann G., Bancroft J., Braunstein G.D., Burger H., Davis S., Dennerstein L., et al. Female androgen insufficiency the Princeton Consensus Statement on definition, classification, and assessment. Fertil Steril. 77:2002;660-665
4. Nathanson I.T., Towne L.E. The urinary excretion of estrogens, androgens and FSH following the administration of testosterone to human female castrates. Endocrinology. 25:1939;754-758
5. Geist S.H., Salmon U.J. Androgen therapy in gynecology. JAMA. 117:1941;2207-2213
6. Kurzrok L, Rothbart H. Treatment of female menopause with methyltestosterone and stilbestrol. Am J Surg 1942;LVI:636-9
7. Greenblatt R.B. Androgenic therapy in women. Endocrinology. 2:1942;665-666
8. Salmon U.J., Geist S.H. Effects of androgens upon libido in women. J Clin Endocrinol Metab. 3:1943;235-238
9. Greenblatt R.B., Warfield W.E., Garner J.F., Calk G.L., Harrod J.P. Evaluation of estrogen, androgen, and estrogen-androgen combination and a placebo in the treatment of menopause. J Clin Endocrinol Metab. 10:1950;1547-1558
10. Waxenberg S.E., Drelich M.G., Sutherland A.M. The role of hormones in human behavior changes in female sexuality after adrenalectomy. J Clin Endocrinol Metab. 19:1959;193-202
11. Kupperman H.S., Wetchler B.B., Blatt M.H.G. Contemporary therapy of the menopausal syndrome. JAMA. 171:1959;103/1627-113/1637
12. Shifren J.L., Braunstein G.D., Simon J.A., Casson P.R., Buster J.E., Redmond G.P., et al. Transdermal testosterone treatment in women with impaired sexual function after oopherectomy. N Engl J Med. 343:2000;682-688
13. Lobo R.A., Rosen R.C., Yang H.M., Block B., van der Hoop R.G. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril. 79:2003;1341-1352
14. Goldstat R., Briganti E., Tran J., Wolfe R., Davis S.R. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause. 10:2003;390-398
15. Braunstein GD, Shifren J, Simon J, Lucas J, Rodenberg C, Watts N. Testosterone patches for the treatment of low sexual desire in surgically menopausal women. [abstract no. 60]. In: Program and abstracts of the 14th annual meeting of The North American Menopause Society. Miami Beach: The North American Menopause Society, 2003
16. Longcope C. Androgen metabolism and the menopause. Sem Reprod Endocrinol. 16:1998;111-115
17. Vermeulen A. Plasma androgens in women. J Reprod Med. 43:1998;725-733
18. Plouffe L.J. Ovaries, androgens and the menopause practical application. Sem Reprod Endocrinol. 16:1998;117-120
19. Simon J.A. Estrogen replacement therapy effects on endogenous androgen milieu. Fertil Steril. 77:2002;S77-S82
20. Dunn J.F., Nisula B.C., Rodbard D. Transport of steroid hormones binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab. 53:1981;58-68
21. Simpson E.R. Aromatization of androgens in women current concepts and findings. Fertil Steril. 77:2002;S6-S10
22. Guay A.T. Screening for androgen deficiency in women methodological and interpretive issues. Fertil Steril. 77:2002;S83-S88
23. Boots L.R., Potter S., Potter D., Azziz R. Measurement of total serum testosterone levels using commercially available kits high degree of between kit variability. Fertil Steril. 69:1998;286-292
24. Vermeulen A., Verdonck L., Kaufman J.M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 84:1999;3666-3672
25. Longcope C. Adrenal and gonadal androgen secretion in normal females. Clin Endocrinol Metab. 15:1986;213-228
26. Longcope C., Hunter R., Franz C. Steroid secretion by the postmenopausal ovary. Am J Obstet Gynecol. 138:1980;564-568
27. Serio M., Mannelli M., Calabresi E., Orlando C., Giannotti P. Ovarian and adrenal secretion of androgens. Molinatti G.M., Martini L., James V.H.T. Androgenization in women. 1983;15-24 Raven Press, New York
28. Adashi E.Y. The climacteric ovary as a functional gonadotropin-driven androgen-producing gland. Fertil Steril. 62:1994;20-27
29. Judd H.L., Fournet N. Changes of ovarian hormonal function with aging. Experiment Gerontol. 29:1994;285-298
30. Labrie F., Luu-the V., Labrie C., Belanger A., Simard J., Lin S., et al. Endocrine and intracrine sources of androgens in women inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev. 24:2003;152-182
31. Labrie F., Belanger A., Cusan L., Candas B. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but their metabolites intracrinology. J Clin Endocrinol Metab. 82:1997;2403-2409
32. Zumoff B., Strain G.W., Miller L.K., Rosner W. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab. 80:1995;1429-1430
33. Lasley B.L., Santoro N., Randolf J.F., Gold E.B., Crawford S., Weiss G., et al. The relationship of circulating dehydroepiandtrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endorcrinol Metab. 87:2002;3760-3767
34. Vermeulen A., Verdonck L. Plasma androgen levels during the menstrual cycle. Am J Obstet Gynecol. 125:1976;491-494
35. Rannevik G., Jeppsson S., Johnell O., Bjerre B., Laurell-Borulf Y., Svanberg L. A longitudinal study of the perimenopausal transition altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas. 21:1995;103-113
36. Bancroft J., Cawood E.H.H. Androgens and the menopause a study of 40-60 year-old women. Clin Endocrinol. 45:1996;577-587
37. Burger H.G., Dudley E.C., Cui J., Dennerstein L., Hopper J.L. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab. 85:2000;2832-2838
38. 19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab. 82:1997;2396-2402
39. Hornsby P.J. Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline. Ann NY Acad Sci. 774:1995;29-46
40. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 59:1984;551-555
41. Ravaglia G., Forti P., Maioli F., Boschi F., Bernardi M., Pratelli L., et al. The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-olds. J Clin Endocrinol Metab. 81:1996;1173-1178
42. Sarrel P., Dobay B., Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. J Reprod Med. 43:1998;847-856
43. Bancroft J., Sanders D., Davidson D., Warner P. Mood, sexuality, hormones, and the menstrual cycle. III. Sexuality and the role of androgens. Psychosom Med. 45:1983;509-516
44. Persky H., Lief A.I., Strauss D., Miller W.R., O'Brien C.P. Plasma testosterone levels and sexual behavior of couple. Arch Sex Behav. 7:1987;157-173
45. Morris N.M., Udry J.D., Khan-Dawood F., Dawood M.Y. Marital sexual frequency and midcycle female testosterone. Arch Sex Behav. 16:1987;27-38
46. Van Goozen S.H.M., Wiegant V.M., Endert E., Helmond F.A., Van de Poll N.E. Psychoendocrinological assessment of the menstrual cycle the relationship between hormones, sexuality, and mood. Arch Sex Behav. 26:1997;359-382
47. Riley A., Riley E. Controlled studies on women presenting with sexual drive disorder. I. Endocrine status. J Sex Marital Ther. 26:2000;269-283
48. Floter A., Nathorst-Boos J., Carlstrom B.K., von Schoultz B. Androgen status and sexual life in perimenopausal women. Menopause. 4:1997;95-100
49. Persky H., Dreisbach L., Miller W.R., O'Brien C.P., Khan M.A., Lief H.I., et al. The relation of plasma androgen levels to sexual behaviors and attitudes of women. Psychosom Med. 44:1982;305-319
50. McCoy N.L., Davidson J.M. A longitudinal study of the effects of menopause on sexuality. Maturitas. 7:1985;203-210
51. Dennerstein L., Randolph J., Taffe J., Dudley E., Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril. 77:2002;S42-S48
52. Bachmann G.A., Leiblum S.R., Kemmann E., Colburn D.W., Swartzman L., Shelden R. Sexual expression and its determinants in the post-menopausal woman. Maturitas. 6:1984;19-29
53. Cutler W.B., Garcia C.R., Huggins G.R., Preti G. Sexual behavior and steroid levels among gynecologically premature premenopausal women. Fertil Steril. 48:1986;496-502
54. Schreiner-Engel P., Schiavi R.C., White D., Ghizzani A. Low sexual desire in women the role of reproductive hormones. Horm Behav. 23:1989;221-234
55. Bancroft J., Sherwin B., Alexander G.M., Davidson D.W., Walker A. Oral contraceptives, androgens, and the sexuality of young women. II. The role of androgens. Arch Sex Behav. 20:1991;121-135
56. Cawood E.H.H., Bancroft J. Steroid hormones, the menopause, sexuality and well-being of women. Psycholog Med. 26:1996;925-936
57. Studd J.W.W., Collins W.P., Chakravarti S., Newton J.R., Oram D., Parsons A. Oestradiol and testosterone implants in the treatment of psychosexual problems in the postmenopausal woman. Br J Obstet Gynaecol. 84:1977;314-315
58. Dennerstein L., Dudley E.C., Hopper J.L., Burger H. Sexuality, hormones and the menopausal transition. Maturitas. 26:1997;83-93
59. Rosen R.C. Assessment of female sexual dysfunction review of validated methods. Fertil Steril. 77:2002;S89-S93
60. Miller K.K., Sesmilo G., Schiller A., Schoenfeld D., Burton S., Klibanski A. Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab. 86:2001;51-57
61. Arlt W., Callies F., van Vlijmen J.C., Koehler I., Reincke M., Bidlingmaier M., et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. 341:1999;1013-1020
62. Hughes C.L., Wall L.L., Creasman W.T. Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause. Gynecol Oncol. 40:1991;42-45
63. Judd H.L., Lucas W.E., Yen S.S. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol. 118:1974;793-798
64. Gravholt C.H., Svenstrup B., Bennett P., Christiansen J.S. Reduced androgen levels in adult Turner syndrome influence of female sex steroids and growth hormone status. Clin Endocrinol. 50:1999;791-800
65. Hartmann B.W., Kirchengast S., Albrecht A., Laml T., Soregi G., Huber J.C. Androgen serum levels in women with premature ovarian failure compared to fertile and menopausal controls. Gynecolog Obstet Invest. 44:1997;127-131
66. Hunt P.J., Gurnell E.M., Huppert F.A., Richards C., Prevost A.T., Wass J.A.H., et al. Improvement in mood and fatigue after dehydroepiandrosterone treatment in Addison's disease in a randomized double-blind trial. JCEM. 85:2000;4650-4656
67. Lovas K., Gabre-Medhin G., Trovik T.S., Fougner K.J., Uhlving S., Nedrebo B.G., et al. Replacement of dehydroepiandrosterone in adrenal failure no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab. 88:2003;1112-1118
68. Abraham G.E. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab. 39:1974;340-346
69. Heinonen P.K., Koivula T., Rajaniemi H., Pystynen P. Peripheral and ovarian venous concentrations of steroid and gonadotropin hormones in postmenopausal women with epithelial ovarian tumors. Gynecol Oncol. 25:1986;1-10
70. Laughlin G.A., Barrett-Connor E., Kritz-Silverstein D., von Muhlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women the Rancho Bernardo Study. J Clin Endocrinol Metab. 85:2000;645-651
71. Vehkavaara S., Hakala-Ala-Pietilä T., Virkamaki A., Bergholm R., Ehnholm C., Hovatta O., et al. Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women. Circulation. 102:2000;2687-2693
72. Braunstein GD. Androgen insufficiency in women. In: Carr B, Blackwell R, Azziz R, eds. Essential reproductive medicine. New York: McGraw-Hill. In press
73. Braunstein G.D. Androgen insufficiency in women summary of critical issues. Fertil Steril. 77:2002;S94-S99
74. Notelovitz M. Androgen effects on bone and muscle. Fertil Steril. 77:2002;S34-S41
75. Sherwin B.B., Gelfand M.M. Differential symptoms response to parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol. 1512:1985;153-159
76. Sherwin B.B., Gelfand M.M., Brender W. Androgen enhances sexual motivation in females a prospective, crossover study of sexual steroid administration in the surgical menopause. Psychosom Med. 47:1985;339-351
77. Myers L.S., Dixen J., Morrissette D., Carmichael M., Davidson J.M. Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women. J Clin Endocrinol Metab. 70:1990;1124-1131
78. Burger H., Hailes J., Nelson J. Effect of combined implants of oestradiol and testosterone on libido in post-menopausal women. Br Med J. 294:1987;936-937
79. Davis S.R., McCloud P., Strauss B.J.G., Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas. 21:1995;227-236
80. Dow M.G.T., Hart D.M. Hormonal treatments of sexual unresponsiveness in postmenopausal women a comparative study. Br J Obstet Gynaecol. 90:1983;361-366
81. Burger H.G., Hailes J., Menelaus M., Nelson J., Hudson B., Balazs N. The management of persistent menopausal symptoms with oestradiol-testosterone implants clinical, lipid and hormonal results. Maturitas. 6:1984;351-358
82. Sherwin B.B. Affective changes with oestrogen and androgen replacement therapy in surgically menopausal women. J Affect Dis. 14:1988;177-187
83. Sherwin B.B., Gelfand M. The role of androgen in the maintenance of sexual functioning in ovarectomized women. Psychosom Med. 49:1987;397-409
84. Tuiten A., Laan E., Panhuysen G., Everaerd W., Haan E.D., Koppeschaar H., et al. Discrepancies between genital responses and subjective sexual function during testosterone substitution in women with hypothalamic amenorrhea. Psychsom Med. 58:1996;234-241
85. Morales A.J., Haubrich R.H., Hwang J.Y., Asakura H., Yen S.S. The effect of six months treatment with a 100 mg daily dose of dehydropepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxf). 49:1998;421-432
86. Barnhart K.T., Freeman E., Grisso J.A., Rader D.J., Sammel M., Kapoor S., et al. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and helath-related quality of life. J Clin Endocrinol Metab. 84:1999;3896-3902
87. Baulieu E., Thomas G., Legrain S., Lahlou N., Roger N., Debuire B. Dehydroepiandrosterone (DHEA), DHEA sulphate, and aging contribution of the DHEAge study to a sociobiomedical issue. Proc Natl Acad Sci USA. 97:2000;4279-4284
88. Johannsson G., Burman P., Wiren L., Engstrom B.E., Nilsson A.G., Ottosson M., et al. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women a placebo-controlled trial. J Clin Endocrinol Metab. 87:2002;2046-2052
89. Kicovic P.M., Cortes-Prieto J., Luisit M., Milojevic S., Franchi F. Placebo-controlled cross-over study of effects of Org OD 14 in menopausal women. Reproduction. 6:1981;81-91
90. Nevinny-Stickel J. Double-blind cross-over study with Org OD 14 and placebo in postmenopausal patients. Arch Gynecol. 234:1983;27-31
91. Palacios S., Menendez C., Jurado A.R., Castano R., Vargas J.C. Changes in sex behaviour after menopause effects of tibolone. Maturitas. 22:1995;155-161
92. Laan E., van Lunsen R.H., Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric. 4:2001;28-41
93. Moore R.A. Livial a review of clinical studies. Brit J Obstet Gynaecol. 106:(Suppl 19):1999;1-21
94. Davis S.R. The effects of tibolone on mood and libido. Menopause. 9:2002;162-170
95. Parasrampuria J., Schwartz K., Petesch R. Quality control of dehydroepiandrosterone dietary supplement products. JAMA. 280:1998;1565
96. Kicman A.T., Bassindale T., Cowan D.A., Dale S., Hutt A.J., Leeds A.R. Effect of androstenedione ingestion on plasma testosterone in young women; a dietary supplement with potential health risks. Clin Chem. 49:2003;167-169
97. Leder B.Z., Leblanc K.M., Longcope C., Lee H., Catlin D.H., Finkelstein J.S. Effects of oral androstenedione administration on serum testosterone and estradiol levels in postmenopausal women. J Clin Endocrinol Metab. 87:2002;5449-5454
98. Barrett-Connor E., Timmons C., Young R., Wiita B. Estratest Working Group. Interim Safety Analysis of a two-year study comparing oral estrogen-androgen and conjugated estrogens in surgically menopausal women. J Womens Health. 5:1996;593-602
99. Raisz L.G., Wiita B., Artis A., Bowen A., Schwartz S., Trahiotis M., et al. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab. 81:1996;37-43
100. Phillips E., Bauman C. Safety surveillance of esterified estrogens-methyltestosterone (Estratest and Estratest HS) replacement therapy in the United States. Clin Therap. 19:1997;1070-1084
101. Barrett-Connor E., Young R., Notelovitz M., Sullivan J., Wiita B., Yang H., Nolan J. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. J Reprod Med. 44:1999;1012-1020
102. Hickok L.R., Toomey C., Speroff L. A comparison of esterified estrogens with and without methyltestosterone effects on endometrial histology and serum lipoproteins in postmenopausal women. Obstet Gynecol. 82:1993;919-924
103. Watts N.B., Notelovitz M., Timmons M.C., Addison W.A., Wiita B., Downey L.J. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol. 85:1995;529-537
104. Farish E., Fletcher C.D., Hart D.M., Al Azzawi F., Abdalla H.I., Gray C.E. The effects of hormone implants on serum lipoproteins and steroid hormones in bilaterally oophorectomised women. Acta Endocrinol. 106:1984;116-120